Monkeypox’s Multisectoral Challenge: Why One Health is the key?

Authors

  • Neeraj Ranakoti All India Institute of Medical Sciences, Rishikesh, Uttarakhand https://orcid.org/0009-0009-9583-1483
  • Meenu Singh All India Institute of Medical Sciences, Rishikesh, Uttarakhand
  • Priyanka Naithani All India Institute of Medical Sciences, Rishikesh, Uttarakhand https://orcid.org/0009-0008-8602-4367
  • Diksha Silswal All India Institute of Medical Sciences, Rishikesh, Uttarakhand https://orcid.org/0009-0006-1170-3408
  • Mahendra Singh All India Institute of Medical Sciences, Rishikesh, Uttarakhand

DOI:

https://doi.org/10.47203/IJCH.2025.v37i02.029

Keywords:

Zoonotic Disease, One Health, Mpox, WHO

Abstract

The global emergence of mpox (Monkeypox), a zoonotic disease attributed to the monkeypox virus (MPXV), presents a considerable public health dilemma, particularly in the context of the ongoing ramifications of the COVID-19 pandemic. This pathogen, which originated in Central and West Africa and was first documented in human cases in 1970, has proliferated internationally, with the outbreak in 2022 prompting the World Health Organization (WHO) to classify it as a Public Health Emergency of International Concern. The epidemiological profile of mpox indicates notable variations in its distribution, with elevated incidence rates particularly observed among male demographics, notably within the gay, bisexual, and other men who have sex with men (MSM) communities. The primary mode of transmission is through direct exposure to infected biological fluids, lesions, or mucous membranes, while environmental reservoirs and potential vertical transmission are considered to play a lesser role. Populations deemed vulnerable, including those with immunocompromised states and individuals situated in socioeconomically disadvantaged environments, experience increased susceptibility. Clinical features, such as lymphadenopathy, serve to distinguish mpox from smallpox. Diagnostic techniques, including polymerase chain reaction (PCR) and advanced deep learning models, provide high levels of accuracy, although rapid antigen testing remains inconsistent in reliability. Current therapeutic interventions encompass tecovirimat, cidofovir, and brincidofovir, with tecovirimat demonstrating the most substantial efficacy. Severe cases necessitating hospitalization may arise due to complications such as proctitis, secondary infections, or conditions like encephalitis. Adopting a One Health framework, which amalgamates human, animal, and environmental health considerations, is imperative for the timely detection, surveillance, and management of prospective outbreaks. Collaborative initiatives and technological advancements, such as Geographic Information Systems (GIS), are crucial in refining response strategies and achieving enduring public health objectives.

Downloads

Download data is not yet available.

References

Miranda MNS, Pingarilho M, Pimentel V, et al. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2. Front Microbiol. 2022;13:889643.

Kang Y, Ahmad S. The emerging epidemics in recent: mpox. Life Cycle 2023;3:e3

Sarker R, Roknuzzaman ASM, Shahriar M, Bhuiyan MA, Islam MR. The WHO has ended public health emergency of international concern for mpox: assessment of upside and downside of this decision. Int J Surg. 2023;109(10):3238-3239.

Global Mpox Trends. Available from: https://worldhealthorg.shinyapps.io/mpx_global/#sec-global Accessed on 25/04/2025

Gao L, Shi Q, Dong X, Wang M, Liu Z, Li Z. Mpox, Caused by the MPXV of the Clade IIb Lineage, Goes Global. Tropical Medicine and Infectious Disease. 2023; 8(2):76

Hossain A, Monem MA, Rahman M, Raza R. Mpox (monkeypox): a comprehensive updated of current epidemic evidence. Sci One Health. 2024;4:100100.

Chan, A. S. W. Unveiling Racial and Ethnic Disparities in MPOX Virus Vaccine Distribution and Demographic Patterns in the United States. Preprints 2023, 2023110275.

Scarpa F, Azzena I, Ciccozzi A, Branda F, Locci C, Perra M, et al. Update of the Genetic Variability of Monkeypox Virus Clade IIb Lineage B.1. Microorganisms [Internet]. 2024;12(9):1874.

Sberna G, Rozera G, Minosse C, Bordi L, Mazzotta V, D’Abramo A, et al. Role of Direct Sexual Contact in Human Transmission of Monkeypox Virus, Italy. Emerg Infect Dis [Internet]. 2024;30(9):1829–33.

Pan D, Nazareth J, Sze S, Martin CA, Decker J, Fletcher E, et al. Transmission of monkeypox/mpox virus: A narrative review of environmental, viral, host, and population factors in relation to the 2022 international outbreak. J Med Virol [Internet]. 2023;95(2):e28534.

Abiodun OE, Ayegbusi FD, Olukayode A, Adegbola EO, Okuh BA. Assessing the Dynamics of Monkeypox Transmission: A Comprehensive Mathematical Modelling Approach. International Conference on Science, Engineering and Business for Driving Sustainable Development Goals, SEB4SDG 2024. 2024;

Ekerin O, Shomuyiwa DO, Ogunkola IO, Adebisi YA, Manirambona E. Mpox as an emerging health threat for survivors of sex trafficking. Tropical Medicine and International Health. 2024 Jan 1;

Mshenga MM, Mussa IA, Haji SH. Public health response to Mpox: Safeguarding vulnerable Key Populations and People Living with HIV in Zanzibar. AIDS Res Ther. 2024;21(1):65.

Shabil M, Gaidhane S, Roopashree R, Kaur M, Srivastava M, Barwal A, et al. Association of HIV infection and hospitalization among mpox cases: a systematic review and meta-analysis. BMC Infect Dis. 2025;25(1):102.

Musuka G, Moyo E, Tungwarara N, et al. A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: lessons learned and evolving practices. IJID Reg. 2024;12:100402.

Luo Q, Han J. Preparedness for a monkeypox outbreak. Infectious Medicine [Internet]. 2022;1(2):124.

Keum BT, Hong C, Beikzadeh M, Cascalheira CJ, Holloway IW. Mpox Stigma, Online Homophobia, and the Mental Health of Gay, Bisexual, and Other Men Who Have Sex with Men. LGBT Health [Internet]. 2023;10(5):408–10.

Karan A; infectious disease doctor, Contag C; infectious disease doctor, Barry M; senior associate dean of global health. Health inequities continue to drive the public health threat of mpox. BMJ. 2023;381:1391.

Shen M, Lai H, Zhang L. Targeted interventions for individuals at high risk is essential for mpox control. Lancet Infect Dis [Internet]. 2024;24(1):8–9.

Branda F, Romano C, Ciccozzi M, Giovanetti M, Scarpa F, Ciccozzi A, et al. Mpox: An Overview of Pathogenesis, Diagnosis, and Public Health Implications. J Clin Med [Internet]. 2024 Apr 1 [cited 2025 Mar 12];13(8):2234.

Hetta HF, Alharbi AA, Alsharif SM, Alkindy TT, Alkhamali A, Albalawi AS, et al. Mpox Virus Infection and Vaccination: Immunopathogenesis and Exploring the Link to Neuropsychiatric Manifestations. Immuno. 2024;4(4):578–600.

Adelakun AA, Onaolapo MC, Olorunsesan MD, Oluwole F, Ajayi AF. Mpox: lessons learnt from previous viral outbreaks applicable to the ongoing outbreak. African Journal of Clinical and Experimental Microbiology. 2024;25(4):371–80.

Prasad M. Mpox: A zoonotic threat that demands a One Health response. Journal of the Epidemiology Foundation of India [Internet]. 2024;2(3):86–8.

Titanji BK, Hazra A, Zucker J. Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies: A Review. JAMA. 2024;332(19):1652-1662.

Unnikrishnan G, Singh A, Purohit A. Diagnostic accuracy of polymerase chain reaction for detection of mpox in humans. Revista Panamericana de Salud Pública [Internet]. 2024;48:1.

Atceken N, Bayaki I, Can B, Yigci D, Tasoglu S. Mpox disease, diagnosis, and point of care platforms. Bioeng Transl Med. 2025; https://aiche.onlinelibrary.wiley.com/doi/epdf/10.1002/btm2.10733

Idroes GM, Noviandy TR, Emran T Bin, Idroes R. Explainable Deep Learning Approach for Mpox Skin Lesion Detection with Grad-CAM. Heca Journal of Applied Sciences. 2024;2(2):54–63.

Elie IN, Anushri S, Alessandra RR, Konstantina K, Daniel MB, Marithé MN, Emile MM, Hugues MN, Jacob P, Yusra H, Susan G, Christopher T. Williams, Dominic Wooding, Juvenal Nkeramahame, Mikaela Watson, Hayley E Hardwick, Malcolm G Semple, J Kenneth Baillie, Jake Dunning, Thomas E Fletcher, Thomas Edwards, Devy M. Emperador, Hugo Kavunga-Membo, Ana Cubas-AtienzarmedRxiv 2024.11.07.24316894;

Krishna S, Teotia D, Yadav M, Mahilkar S, Suchiita A, Saxena A, et al. Monkeypox (Mpox): Diagnosis and Emerging Challenges. Yale Journal of Biology and Medicine. 2024;97(4):529–34.

Braddick M, Singh KP. Therapeutic agents for the treatment of human mpox. Curr Opin Infect Dis. 2024;37(6):518-525.

Shabil M, Khatib MN, Ballal S, et al. Effectiveness of Tecovirimat in Mpox Cases: A Systematic Review of Current Evidence. J Med Virol. 2024;96(12):e70122.

Fink DL, Callaby H, Luintel A, Beynon W, Bond H, Lim EY, et al. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Lancet Infect Dis. 2023;23(5):589–97.

Kobaidze K, Maleque N, Geer B, Dressler D. Clinical progress note: Monkeypox infection among hospitalized patients. J Hosp Med. 2023;18(2):164–8.

Henao-Martínez AF, Orkin CM, Titanji BK, Rodriguez-Morales AJ, Salinas JL, Franco-Paredes C, et al. Hospitalization risk among patients with Mpox infection—a propensity score matched analysis. Ther Adv Infect Dis. 2023 Jan;10.

Massip E, Alcaraz I, Vuotto F, Baclet V, Viget N, Duflos S, et al. Mpox : épidémiologie et diagnostics différentiels lors de l’épidémie 2022. Médecine et Maladies Infectieuses Formation. 2023;2(2):S83.

Islam M, Rahman A, Rahman M. One Health: A must-needed approach for dealing with Monkeypox. Journal of Research in Veterinary Sciences. 2024;3(2):52-55.

Bioethics Clin App A, Tamayo VM, Pinilla SJ, Morales BJ, Lima G LA. Annals of Bioethics & Clinical Applications Committed to Create Value for Researchers Zoonosis from “One Health”: Ethical Reflections on its Relevance Zoonosis from “One Health”: Ethical Reflections on its Relevance. 2024;

Olumuyiwa Tolulope Ojeyinka, Toritsemogba Tosanbami Omaghomi. Integrative strategies for zoonotic disease surveillance: A review of one health implementation in the United States. World Journal of Biology Pharmacy and Health Sciences [Internet]. 2024;17(3):075–86.

Singh S, Jha SK. One health: a long road ahead. Int J Community Med Public Health [Internet]. 2023;10(7):2657–60.

Kibenge FSB. Continuous surveillance and viral discovery in animals and humans are a core component of a one-health approach to address recent viral reverse zoonoses. J Am Vet Med Assoc. 2023;261(6):789–97.

Downloads

Published

2025-04-30

How to Cite

1.
Ranakoti N, Singh M, Naithani P, Silswal D, Singh M. Monkeypox’s Multisectoral Challenge: Why One Health is the key?. Indian Journal of Community Health [Internet]. 2025 Apr. 30 [cited 2025 Jul. 9];37(2):347-52. Available from: https://iapsmupuk.org/journal/index.php/IJCH/article/view/3213

Issue

Section

Perspective

Dimensions Badge

Most read articles by the same author(s)